We carried out immunohistochemical analysis of ezrin and phospho-ezrin (T567) in patient samples of papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), follicular variant of papillary thyroid carcinoma (FVPTC) and follicular adenoma (FA). Here, EZR is linked to thyroid gland papillary carcinoma.